Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Analytical Biochemistry|March 10, 2001
Simultaneous detection of NOS-3 protein expression and nitric oxide production using a flow cytometerM J Havenga, B van Dam, B S Groot, et al.Cell Regulation|October 1, 1991
Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradationP H Quax, N Pedersen, M T Masucci, et al.Protein Engineering|December 1, 1990
Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesisE J Weening-Verhoeff, P H Quax, R T van Leeuwen, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1995
Properties of metastasizing and nonmetastasizing human melanoma cellsG N van Muijen, E H Danen, T J de Vries, et al.Journal of Virology|March 10, 2001
Improved adenovirus vectors for infection of cardiovascular tissuesM J Havenga, A A Lemckert, J M Grimbergen, et al.Clinical & Experimental Metastasis|October 11, 2001
Antibodies to PAI-1 alter the invasive and migratory properties of human tumour cells in vitroT D Brooks, J Slomp, P H Quax, et al.Developmental Biology|May 1, 1992
Modulation of activities and RNA level of the components of the plasminogen activation system during fusion of human myogenic satellite cells in vitroP H Quax, E Frisdal, N Pedersen, et al.British Journal of Rheumatology|January 1, 1997
Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritisH K Ronday, H H Smits, P H Quax, et al.Invasion & Metastasis|January 1, 1993
Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastasesC F Sier, P H Quax, H J Vloedgraven, et al.The Journal of Cell Biology|October 1, 1991
Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradationP H Quax, G N van Muijen, E J Weening-Verhoeff, et al.Pageof 4